← Return to Shingles Vaccine (Shingrix): Is it advisable for transplant patients?

Discussion

Shingles Vaccine (Shingrix): Is it advisable for transplant patients?

Transplants | Last Active: Jun 28, 2022 | Replies (111)
Comment receiving replies
@athenalee

“Protective immunity to the flu virus is driven mainly by antibodies (Fig. 1) made by B cells.” - https://www.nature.com/articles/d41586-020-02556-2#ref-CR2

There are different types of B cells. Including the memory ones from pretransplant day flue shots we have received. So, to me that seems to be our hope. But, I don’t see how getting the Covid vaccine or any additional vaccines will help those of us on immunosuppressants, since our bodies are now not producing B cells to repel viruses we are newly exposed to. 😷

Jump to this post

Replies to "“Protective immunity to the flu virus is driven mainly by antibodies (Fig. 1) made by B..."
estrada53 | @estrada53 | Jul 29, 2021

Thanks@athenalee.
I think the question of the viability of t and b cells helping us out is the next topic if research at JH. We'll see what happens but I am not super hopeful. My hope is more of a wish. 🙂

VIEW AND REPLY